semaglutide removed from shortage list fda resolved feb 21 2025 Novo's Wegovy and Ozempic US list, compounders on notice FDA Declares Shortage of Novo – The FDA recently removed semaglutide

It is not primarily a weight loss drug, but it helps

The interactions between metabolic and immune factors are complex and not yet fully understood

Seek urgent medical assistance if you develop: severe and persistent abdominal pain repeated vomiting or inability to keep fluids down swelling of the face, lips, tongue or throat difficulty breathing severe dizziness, confusion or fainting sudden loss or rapid deterioration of vision symptoms of severe low blood sugar when using insulin or a sulphonylurea Suspected adverse reactions can also be reported through the MHRA Yellow Card scheme

Some reports have demonstrated that more than 50% of patients with depression experience chronic and recurrent problems throughout their lifetime, and that depressive symptoms can gradually aggravate and lead to suicide if patients are not treated with proper drugs or counseling (Monroe and Harkness, 2005